The Bleeding With Antithrombotic Therapy Study 2 (BAT2)

National Cerebral and Cardiovascular Center, Japan

Status: Completed

Conditions: Cerebrovascular and Cardiovascular Diseases

Treatments: Drug: Any oral antithrombotics (antiplatelets or anticoagulants)

Study type: Observational

Funder types: Other

Identifiers

NCT02889653

16ek0210055h

000023669 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to determine the incidence and severity of bleeding complications in patients with cerebrovascular and cardiovascular diseases treated with oral antithrombotic therapy.

Enrollment: 5,306 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with cerebrovascular or cardiovascular diseases who start or continue taking oral antithrombotics (antiplatelets and/or anticoagulants) to prevent vascular events
• Patients who are able to receive MRI
• Provision of written informed consent either directly or by a suitable surrogate

Exclusion criteria

• MRI contraindication
• Any condition that in the opinion of the responsible physician or investigator that renders the patient unsuitable for the study